Search

Your search keyword '"Hassan, R"' showing total 11 results
Start Over Author "Hassan, R" Journal annals of oncology
11 results on '"Hassan, R"'

4. A phase I study of intraperitoneal MCY-M11 Anti-mesothelin CAR for women with platinum resistant high grade serous adenocarcinoma of the ovary, primary peritoneum, or fallopian tube, or subjects with peritoneal mesothelioma with recurrence after prior chemotherapy

Author

Annunziata, C., primary, Dansky-Ullmann, C., additional, Ghobadi, A., additional, Weng, D., additional, Vanas, J., additional, Ekwede, I., additional, Pavelova, M., additional, Keefe, R., additional, Kuo, M., additional, Hassan, R., additional, and Thaker, P., additional

Published
2019
Full Text
View/download PDF

8. A Multi-Center Phase II Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody Amatuximab in Combination with Chemotherapy for Frontline Therapy of Malignant Pleural Mesothelioma: Updated Clinical Outcomes and Correlative Studies

Author

Reck, M., primary, Hassan, R., additional, Jahan, T., additional, Kindler, H.L., additional, Bazhenova, L., additional, Fatato, P., additional, Heyburn, J.W., additional, Parno, J., additional, Maltzman, J.D., additional, and Wallin, B., additional

Published
2012
Full Text
View/download PDF

10. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference

Author

Ahalya Premkumar, Daniel H. Sterman, Robert N. Taub, Paul H. Sugarbaker, R Alexander, Andrew Churg, Ronald C. Kennedy, Hedy L. Kindler, Raffit Hassan, Claire F. Verschraegen, Paolo Boffetta, Karen H. Antman, Victor L. Roggli, Daniel G. Coit, M Onda, Harvey I. Pass, Muzaffer Metintas, P Hausner, Luciano Mutti, Hassan, R., Alexander, R., Antman, K., Boffetta, P., Churg, A., Coit, D., Hausner, P., Kennedy, R., Kindler, H., Metintas, M., Mutti, L., Onda, M., Pass, H., Premkumar, A., Roggli, V., Sterman, D., Sugarbaker, P., Taub, R., and Verschraegen, C.

Subjects
medicine.medical_specialty, business.industry, General surgery, Treatment options, Cancer, Hematology, medicine.disease, Rare cancer, respiratory tract diseases, Surgery, Peritoneal Neoplasm, Oncology, Basic research, Epidemiology, Peritoneal mesothelioma, Medicine, Mesothelioma, business
Abstract

Peritoneal mesothelioma is a rare cancer of the peritoneum with about 250 new cases diagnosed each year in the United States. It is the second most common site for mesothelioma development and accounts for 10-20% of all mesotheliomas diagnosed in the United States. A meeting sponsored by the NIH Office of Rare Diseases was held in Bethesda, Maryland on September 13 and 14, 2004. The objective of this meeting was to review the epidemiology, biology and current surgical and medical management of peritoneal mesothelioma. In addition, the meeting also discussed clinical and pre-clinical evaluation of novel treatments for mesothelioma as well as ongoing laboratory research to better understand this disease. This report summarizes the proceedings of the meeting as well as directions for future clinical and basic research. © 2006 Oxford University Press.

Published
2006

Catalog

Books, media, physical & digital resources
See catalog results